| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/16/2011 | US20110142924 Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein |
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/16/2011 | US20110142871 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 06/16/2011 | US20110142869 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine |
| 06/16/2011 | US20110142864 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142852 Multispecific antibodies |
| 06/16/2011 | US20110142851 IL6 Immunotherapeutics |
| 06/16/2011 | US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 |
| 06/16/2011 | US20110142845 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF |
| 06/16/2011 | US20110142825 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |
| 06/16/2011 | US20110142791 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | US20110139713 Method of treatment for waste water using microbialgrowth promoter |
| 06/16/2011 | US20110138682 Algal culture production, harvesting , and processing |
| 06/16/2011 | DE102009058169A1 Protein oder Polypeptid zur Bindung an Tubulin und/oder Mikrotubulistrukturen Protein or polypeptide to bind to tubulin and / or Mikrotubulistrukturen |
| 06/16/2011 | DE102004037652B4 Verfahren zur Modulation der Genexpression durch Änderung des CpG Gehalts Process for the modulation of gene expression by changing the CpG content |
| 06/16/2011 | CA2783876A1 New conjugates and compositions for immunotherapy and antitumoral treatment |
| 06/16/2011 | CA2783533A1 Heterologous expression of urease in anaerobic, thermophilic hosts |
| 06/16/2011 | CA2783096A1 Methods and organisms for converting synthesis gas or other gaseous carbon sources and methanol to 1,3-butanediol |
| 06/16/2011 | CA2782451A1 Selective lysis of cells |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/15/2011 | EP2333549A2 Serum bactericidal assay for N. meningitidis specific antisera |
| 06/15/2011 | EP2333105A1 Selective lysis of cells |
| 06/15/2011 | EP2333099A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333098A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333097A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333096A2 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 06/15/2011 | EP2333094A1 Production of polyunsaturated fatty acids using novel cell treatment method |
| 06/15/2011 | EP2333093A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 06/15/2011 | EP2333073A1 Schitzochytrium PKS genes |
| 06/15/2011 | EP2333072A1 Schizochytrium PKS genes |
| 06/15/2011 | EP2333071A1 Schitzochytrium PKS genes |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/15/2011 | EP2333055A1 Subtilase variants |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
| 06/15/2011 | EP2333046A1 Method for production of seed material for microorganisms optimized as catalyst for parallel complex mineralization reaction |
| 06/15/2011 | EP2333045A2 Gene Inactivated Mutants with Altered Protein Production |
| 06/15/2011 | EP2333044A1 Pharmaceutically compatible method for purifying intact bacterial minicells |
| 06/15/2011 | EP2332982A1 Liver X receptor alpha splicing mutant protein, gene thereof and utilization of the same |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332975A1 Human proteins |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332961A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332572A1 Nucleic acid vaccines for prevention of Flavivirus |
| 06/15/2011 | EP2332557A1 Probiotic lactic acid bacteria |
| 06/15/2011 | EP2332556A1 Use of yeasts for treating stomach or intestinal ulcers induced by gastrotoxic agents |
| 06/15/2011 | EP2331691A1 Engineered light-emitting reporter genes and medthods of use |
| 06/15/2011 | EP2331674A1 Identification, characterization, and application of thauera sp. al9:8 useful in microbially enhanced oil recovery |
| 06/15/2011 | EP2331629A1 Starch-based microparticles for the release of agents disposed therein |
| 06/15/2011 | EP1500665B1 METHODS FOR CONSTRUCTING scDb LIBRARIES |
| 06/15/2011 | EP1476462B1 Novel fungal lipase |
| 06/15/2011 | EP1392833B1 Site-targeted transformation using amplification vectors |
| 06/15/2011 | EP1373476B1 Cytochrome p450s and uses thereof |
| 06/15/2011 | EP1012274B2 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| 06/15/2011 | EP0939804B2 NEUTROKINE alpha |
| 06/15/2011 | CN1950392B Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 06/15/2011 | CN1843380B Application of metabolin of staphylococcus aureus in preparation, treatment and drags of easing retinal pigment degenerative disease |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN1452656B Lipoxygenase |
| 06/15/2011 | CN1226923B Process for preparing granular microbial biomass and isolation of valuable compounds therefrom |
| 06/15/2011 | CN102099483A Methods and processes for producing organic acids |
| 06/15/2011 | CN102099469A Novel protein having endoglucanase activity, DNA of the protein, and use of the same |
| 06/15/2011 | CN102099468A Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 06/15/2011 | CN102099465A Modified endolysin ply511 |
| 06/15/2011 | CN102099461A Yeast having immunopotentiating effect and food or feed |
| 06/15/2011 | CN102099460A Filamentous fungi with inactivated protease genes for altered protein production |
| 06/15/2011 | CN102098929A Composition of soluble indigestible fibre and of eukaryotic organisms with a polysaccharide wall, used in the well-being field |
| 06/15/2011 | CN102098927A Aspergillus carneus strain and use thereof |
| 06/15/2011 | CN102094040A Gene engineering bacterium for producing tryptase, and construction method and application thereof |
| 06/15/2011 | CN102094039A Prokaryotic expression and purification method of transgenic rice Bt protein cry2a |
| 06/15/2011 | CN102094038A Prokaryotic expression and purification method of transgenic rice Bt protein crylc |
| 06/15/2011 | CN102094031A Gene contained in A.xylosoxidans LHB21 strain and used for coding catechol 2,3-dioxygenase |
| 06/15/2011 | CN102094028A Chinese rose RcLEA coding sequence and application thereof |
| 06/15/2011 | CN102094018A BGIos332 gene and application thereof |
| 06/15/2011 | CN102094017A BGIos 372 gene and application thereof |
| 06/15/2011 | CN102094016A BGIos405 gene and application thereof |
| 06/15/2011 | CN102094015A BGIos416 gene and application thereof |
| 06/15/2011 | CN102094014A BGIos1003 gene and application thereof |
| 06/15/2011 | CN102094013A BGIos1005 gene and application thereof |
| 06/15/2011 | CN102094012A BGIos1027 gene and application thereof |
| 06/15/2011 | CN102094011A BGIos1036 gene and application thereof |
| 06/15/2011 | CN102094010A BGIos1083 gene and application thereof |
| 06/15/2011 | CN102094009A BGIos1087 gene and application thereof |
| 06/15/2011 | CN102094008A BGIos1010 gene and application thereof |
| 06/15/2011 | CN102094007A BGIos1013 gene and application thereof |
| 06/15/2011 | CN102093998A Preparation method of antibacterial peptide cecropin feed additive |
| 06/15/2011 | CN102093984A Hybrid enzyme P450sca2-BMR (Brown Mid Rib), and coding gene and application thereof |
| 06/15/2011 | CN102093976A High-fat chlorella pyrenoidosa culture solution and culture method thereof |
| 06/15/2011 | CN102093975A Composite fungicide for rapid degradation of organic waste and applications thereof |
| 06/15/2011 | CN102093974A Bacillus cereus and multi-stage fermentation method thereof |
| 06/15/2011 | CN102093973A Bacterial strain Pandoraea sp. B-6 for processing high-density papermaking black liquor and application |
| 06/15/2011 | CN102093972A Bacterial strain Comamonas sp. B-9 for processing high-density papermaking black liquor and application thereof |
| 06/15/2011 | CN102093971A Bacterial strain Cupriavidus sp. B-8 for processing high-density papermaking black liquor and application thereof |
| 06/15/2011 | CN102093970A Low-temperature aniline-degrading strain |
| 06/15/2011 | CN102093969A Microbial transformation method of puerarin phosphorylation |